National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 4999 [2020-01384]
Download as PDF
<![CDATA[
4999
Federal Register / Vol. 85, No. 18 / Tuesday, January 28, 2020 / Notices
regulations have been approved by OMB
as listed in the following table:
Topic
807, subpart E ...............
801 .................................
820 .................................
Premarket Notification .............................................................................................................................
Medical Device Labeling Regulations .....................................................................................................
Current Good Manufacturing Practice (CGMP); Quality System (QS) Regulation ................................
Dated: January 22, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–01342 Filed 1–27–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSKJLSW7X2PROD with NOTICES
OMB
control No.
21 CFR part
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS-NIH-CDC-SBIR PHS
2020–1: Co-Delivery and Formulation of
Adjuvants for HIV Vaccine Development
(Topic 76) and Particle-based Co-delivery of
HIV Immunogens as Next-generation HIV
Vaccines (Topic 77).
Date: February 19–21, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Mario Cerritelli, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, MSC–9823, Rockville, MD
20852, 240–669–5199, cerritem@
mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS-NIH-CDC SBIR PHS
2020–1 Topic 84: Antiviral Drugs to Cure
Chronic Hepatitis B Virus Infection.
VerDate Sep<11>2014
17:02 Jan 27, 2020
Jkt 250001
Date: February 20–21, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Yong Gao, Ph.D., Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers
Lane, Room #3G13B, MSC 9823, Rockville,
MD 20892–7616, (240) 669–5048, gaoL2@
niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS-NIH-CDC SBIR PHS
2020–1 Topic 82: Production of Adjuvants.
Date: February 21, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Yong Gao, Ph.D., Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers
Lane, Room #3G13B, MSC 9823, Rockville,
MD 20892–7616, (240) 669–5048, gaoL2@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 22, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01384 Filed 1–27–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
February 26, 2020, 11:00 a.m. to
February 26, 2020, 05:30 p.m., National
Cancer Institute Shady Grove, 9609
Medical Center Drive, Rockville, MD
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
0910–0120
0910–0485
0910–0073
20850 which was published in the
Federal Register on December 30, 2019,
84 FR 71964.
This meeting notice is amended to
change the meeting end time. The
meeting will be now held on February
26, 2020 from 11:00 a.m. to 6:00 p.m. at
the National Cancer Institute Shady
Grove, Room 7W032, 9609 Medical
Center Drive, Rockville, MD 20850. The
meeting is closed to the public.
Dated: January 21, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01377 Filed 1–27–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–11:
SBIR Contract Review.
Date: February 14, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W122, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Anita T. Tandle, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W122,
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 85, Number 18 (Tuesday, January 28, 2020)]
[Notices]
[Page 4999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01384]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2020-1: Co-
Delivery and Formulation of Adjuvants for HIV Vaccine Development
(Topic 76) and Particle-based Co-delivery of HIV Immunogens as Next-
generation HIV Vaccines (Topic 77).
Date: February 19-21, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Mario Cerritelli, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, MSC-9823,
Rockville, MD 20852, 240-669-5199, [email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; HHS-NIH-CDC SBIR PHS 2020-1 Topic
84: Antiviral Drugs to Cure Chronic Hepatitis B Virus Infection.
Date: February 20-21, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Yong Gao, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room #3G13B, MSC 9823,
Rockville, MD 20892-7616, (240) 669-5048, [email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; HHS-NIH-CDC SBIR PHS 2020-1 Topic
82: Production of Adjuvants.
Date: February 21, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Yong Gao, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room #3G13B, MSC 9823,
Rockville, MD 20892-7616, (240) 669-5048, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 22, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-01384 Filed 1-27-20; 8:45 am]
BILLING CODE 4140-01-P
